Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMD) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for OneMedNet (ONMD) over the last 4 years, with Q3 2025 value amounting to $52.6 million.

  • OneMedNet's Shares Outstanding (Weighted Average) rose 7979.84% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year increase of 7979.84%. This contributed to the annual value of $28.1 million for FY2024, which is 28614.3% up from last year.
  • As of Q3 2025, OneMedNet's Shares Outstanding (Weighted Average) stood at $52.6 million, which was up 7979.84% from $36.8 million recorded in Q2 2025.
  • In the past 5 years, OneMedNet's Shares Outstanding (Weighted Average) ranged from a high of $52.6 million in Q3 2025 and a low of $4.0 million during Q4 2022
  • Over the past 4 years, OneMedNet's median Shares Outstanding (Weighted Average) value was $11.5 million (recorded in 2022), while the average stood at $19.3 million.
  • As far as peak fluctuations go, OneMedNet's Shares Outstanding (Weighted Average) crashed by 6492.9% in 2023, and later soared by 58363.81% in 2024.
  • OneMedNet's Shares Outstanding (Weighted Average) (Quarter) stood at $4.0 million in 2022, then skyrocketed by 82.97% to $7.3 million in 2023, then skyrocketed by 286.14% to $28.1 million in 2024, then surged by 87.41% to $52.6 million in 2025.
  • Its last three reported values are $52.6 million in Q3 2025, $36.8 million for Q2 2025, and $34.1 million during Q1 2025.